No Companies Slated to Report w/c 22 December 25: Happy Christmas

Major Biotech Win: AstraZeneca's EU approval for Imfinzi is a clear, high-value catalyst.
Strategic De-risking: AFC Energy executed a pivotal JV, creating a clear commercial path.
Forward-Looking Headwinds: The market punished MJ Gleeson for its FY26 profit warning.

Currently not signing up subscribers : Add your email to the wait list here

Want to become a Runprofiteer ?

Click anywhere on this box to add your name to the sign-up list. You'll get an email invite to get you in early when sign-ups start

SCROLL TO BOTTOM BAR BENEATH REPORT - HIT DIAGONAL ARROW (LOWER RIGHT) TO MAKE FULL SCREEN

Unique Datamining Tools | Powerful DYOR Made Simple